Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (301-310 of 635) with videos related to

Pageof 64
Sort By:
European Heart Journal|April 1, 2017
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trialMarco Valgimigli, Francesco Costa, Yuliya Lokhnygina, et al.
American Heart Journal|June 19, 2018
Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndromeTaku Inohara, Karen Pieper, Daniel M Wojdyla, et al.
Circulation. Cardiovascular Interventions|August 13, 2017
Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention: Findings From CHAMPION PHOENIXMatthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
Lancet (London, England)|March 17, 2009
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II studyRichard C Becker, David J Moliterno, Lisa K Jennings, et al.
Circulation. Cardiovascular Quality and Outcomes|June 11, 2015
Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)James V Freeman, DaJuanicia N Simon, Alan S Go, et al.
Cardiovascular Research|April 7, 2021
Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trialJie Yu, Jingwei Li, Phillip J Leaver, et al.
American Heart Journal|May 13, 2015
Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Fredrik Holmqvist, Ni Guan, Zhaoyin Zhu, et al.
JAMA Cardiology|December 1, 2016
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION TrialsMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Journal of the American College of Cardiology|May 21, 2013
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trendsPierluigi Tricoci, Sergio Leonardi, Jennifer White, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 17, 2013
Release kinetics of circulating cardiac myosin binding protein-C following cardiac injuryDiederik W D Kuster, Adriana Cardenas-Ospina, Lawson Miller, et al.
Pageof 64

Showing results (301-310 of 635) with videos related to

Sort By:
Pageof 64
European Heart Journal|April 1, 2017
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trialMarco Valgimigli, Francesco Costa, Yuliya Lokhnygina, et al.
American Heart Journal|June 19, 2018
Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndromeTaku Inohara, Karen Pieper, Daniel M Wojdyla, et al.
Circulation. Cardiovascular Interventions|August 13, 2017
Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention: Findings From CHAMPION PHOENIXMatthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.
Lancet (London, England)|March 17, 2009
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II studyRichard C Becker, David J Moliterno, Lisa K Jennings, et al.
Circulation. Cardiovascular Quality and Outcomes|June 11, 2015
Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)James V Freeman, DaJuanicia N Simon, Alan S Go, et al.
Cardiovascular Research|April 7, 2021
Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trialJie Yu, Jingwei Li, Phillip J Leaver, et al.
American Heart Journal|May 13, 2015
Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Fredrik Holmqvist, Ni Guan, Zhaoyin Zhu, et al.
JAMA Cardiology|December 1, 2016
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION TrialsMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Journal of the American College of Cardiology|May 21, 2013
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trendsPierluigi Tricoci, Sergio Leonardi, Jennifer White, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 17, 2013
Release kinetics of circulating cardiac myosin binding protein-C following cardiac injuryDiederik W D Kuster, Adriana Cardenas-Ospina, Lawson Miller, et al.
Pageof 64